Personalized Surveillance in Giant Congenital Melanocytic Nevus, Including the Role of AI, Histopathology and MC1R Genotyping: A Case Report

Comprehensive Summary

The study described in Personalized surveillance in giant congenital melanocytic nevus, including the role of AI, histopathology and MC1R genotyping reports a case of a patient with a giant congenital melanocytic nevus (GCMN), a rare skin condition associated with an increased risk of melanoma. The researchers monitored the patient using advanced surveillance methods including total body mapping, artificial intelligence-assisted dermoscopy, histopathological examination, and genetic testing. Genetic analysis identified two high-risk variants in the MC1R gene, which are known to increase susceptibility to melanoma and may explain the patient’s extensive number of nevi. The case highlights how combining AI imaging, pathology, and genomic testing can improve personalized monitoring and early detection strategies for patients at high risk of melanoma.

Outcomes and Implications

The findings of this study highlight the growing importance of personalized surveillance strategies for patients with conditions that significantly increase melanoma risk, such as giant congenital melanocytic nevus. By integrating artificial intelligence clinicians are able to identify malignant changes earlier and tailor monitoring protocols to each patient’s individual risk profile. This approach could improve early melanoma detection while reducing unnecessary procedures or biopsies in patients with numerous nevi. Additionally, the study suggests that combining advanced imaging technologies with genomic information may represent a promising direction for precision dermatology and cancer prevention.